U.S. Luxury Stock News

Check Point Software Technologies (CHKP) closed out FY 2025 with fourth quarter revenue of US$744.9 million and basic EPS of US$2.85, while full year trailing EPS reached US$9.85 on revenue of US$2.7 billion and earnings grew 25% over the past 12 months. Over the last few reported periods, revenue has moved from US$703.7 million in Q4 2024 to US$744.9 million in Q4 2025, with quarterly basic EPS ranging from US$1.77 in Q1 2025 to US$3.34 in Q3 2025 and trailing net income rising from US$845.7...

Dawson Geophysical (DWSN) closed out FY 2025 with fourth quarter revenue of US$26.9 million and basic EPS of US$0.02, alongside net income of US$0.6 million. This set a cleaner finish to a year where the trailing twelve month figures still show a loss of US$1.9 million on US$75.6 million of revenue and a basic EPS loss of US$0.06. Over recent quarters the company has seen quarterly revenue range from US$9.9 million to US$26.9 million, with EPS moving between a loss of US$0.08 and a profit of...

IDEAYA Biosciences (IDYA) recently reported the first patient enrolled in a Phase 1 trial combining IDE849, a DLL3 targeting antibody drug conjugate, with PARG inhibitor IDE161 in several DLL3 upregulated solid tumors. See our latest analysis for IDEAYA Biosciences. The Phase 1 combination update has come as IDEAYA’s share price has eased slightly in the short term, with a 7 day share price return of 3.47% and a 1 year total shareholder return close to 100%. This reflects how recent trial...

ABM Industries stock: recent returns and business mix in focus ABM Industries (ABM) has drawn investor attention after a one-month return of about a 13% decline, adding to a past three-month drop of roughly 9%. This performance has invited closer inspection of its fundamentals. See our latest analysis for ABM Industries. With the share price at $38.70, ABM Industries has seen weaker momentum recently, with a 30 day share price return of a 13.44% decline and a 1 year total shareholder return...

In late March 2026, UWM Holdings CEO Mat Ishbia and SFS Holding Corp sold 3,001,722 Class A shares, shortly after the company reported fourth-quarter 2025 revenue of US$945.00 million that exceeded forecasts and announced advisory and proxy work around its proposed acquisition of Two Harbors Investment Corp. This combination of insider selling, stronger-than-expected quarterly results, and an active acquisition process highlights a period of meaningful corporate change and heightened...

Silicon Motion Technology (NasdaqGS:SIMO) is expanding its automotive grade NAND storage controller portfolio for connected and AI focused vehicles. The company is aligning products with automotive safety and cybersecurity standards such as AEC-Q100, ISO 26262, ISO 21434, and ASPICE Level 3. Its embedded storage solutions are being tailored for advanced driver-assistance systems and autonomous driving platforms. For readers following NasdaqGS:SIMO, this push into automotive storage sits on...

Dianthus Therapeutics recently reported an early “GO” decision in its late-stage CAPTIVATE trial of claseprubart for chronic inflammatory demyelinating polyneuropathy, after meeting interim responder goals ahead of schedule. The US FDA also agreed to multiple company-proposed changes across claseprubart’s development program, including updated screening criteria, lab work, and autoimmune safety monitoring, potentially streamlining current and future studies. We’ll now examine how the early...

Hesai Group recently reported its fourth-quarter and full-year 2025 results, turning a prior-year loss into net income of CNY 435.88 million on CNY 3,027.57 million in sales, and entered a 2026 Supply of Products Framework Agreement under which it will provide LiDAR products and robotic actuators plus manufacturing and support services to Sharpa. By pairing improved profitability with a new Physical AI-focused partnership that bundles hardware and integration services, Hesai is broadening...

Arcutis Biotherapeutics (ARQT) is back in focus after new INTEGUMENT-INFANT Phase 2 data on ZORYVE cream 0.05% in infants with mild to moderate atopic dermatitis, supporting a planned supplemental New Drug Application. See our latest analysis for Arcutis Biotherapeutics. The new clinical data arrives after a mixed stretch for the shares, with a 1-day share price return of 10.45% and 7-day share price return of 7.92% contrasting with a 30-day share price return decline of 12.64%. However, a...

If you are wondering whether Aflac at around US$109.64 is offering fair value or a potential bargain, this article walks through what the current price might be indicating. The stock has been relatively steady recently, with a 2.3% return over the last 7 days, a 3.3% decline over 30 days, and returns of 0.5% decline year to date and 0.2% decline over 1 year, set against much stronger 3 year and 5 year returns of 81.6% and 137.7%. Recent coverage around Aflac has focused on its role as a...

Alkermes (NasdaqGS:ALKS) has begun Phase 3 clinical trials for alixorexton, its orexin 2 receptor agonist for narcolepsy type 1 and type 2. The late stage Brilliance Studies aim to evaluate alixorexton in patients with significant unmet treatment needs in sleep disorders. This marks a new development in Alkermes' pipeline beyond prior focus areas highlighted in earlier coverage. For Alkermes, known for its work in neuroscience and psychiatry, the Brilliance Studies add a new dimension to...

EQT (NYSE:EQT) is advancing its post Olympus Energy integration by preparing multi bench drilling across the Marcellus and Utica formations. The company is conducting field surveys in Upper Burrell, Pennsylvania, as it plans new lateral wells in previously untapped areas. This shift marks a move away from a single target drilling approach toward broader development of its Appalachian acreage. EQT, trading at $61.09, is entering this next phase after a period where attention largely centered...

Advanced Energy Industries (AEIS) has drawn investor attention after a strong past 3 months, with total return around 54% and one year total return near 240%, prompting closer review of its fundamentals. See our latest analysis for Advanced Energy Industries. After a sharp run over the past year, with 1 year total shareholder return close to 240% and a 90 day share price return of about 54%, momentum has cooled in the last month, even though the share price closed at US$322.71 after an 8.2% 1...

LTC Properties (LTC), a real estate investment trust focused on seniors housing and health care properties, has been drawing attention as investors reassess its recent share performance and income profile following recent price moves. See our latest analysis for LTC Properties. The recent pullback, with a 1 month share price return showing a 6.35% decline from US$37.16, comes after a stronger run where the 3 year total shareholder return sits at 36.68%. This suggests that momentum has cooled...

If you are wondering whether Philip Morris International is priced attractively at its current level, the key question is how its share price lines up with the value of its cash flows and assets. The stock last closed at US$165.34, with returns of 0.9% over 7 days, an 11.5% decline over 30 days, 3.1% year to date and 8.3% over the past year. These figures can change how investors think about both growth potential and risk. Recent news coverage has focused on Philip Morris International's...

Infinity Natural Resources (INR) has been drawing attention after recent trading swings, with the stock showing a mix of short term volatility and longer term moves that have left recent returns uneven for investors. See our latest analysis for Infinity Natural Resources. The recent pullback, with a 1 day share price return of a 4.55% decline to US$17.61, comes after a 19.55% 90 day share price return and a softer 1 year total shareholder return of a 4.81% decline. This suggests momentum has...

Why InterDigital stock is back on investor radar InterDigital (IDCC) is in focus after securing a preliminary injunction in Brazil against Transsion over alleged 5G patent infringement, a decision that directly affects device shipments in an important smartphone market. See our latest analysis for InterDigital. The injunction news follows a weaker 30-day share price return of a 17.6% decline and a year-to-date share price return of a 7.4% decline, set against a 1-year total shareholder return...

Aurora Innovation recently used the Morgan Stanley Technology, Media, and Telecom Conference 2026 to outline past progress in driverless trucking, highlighting active driverless operations and plans to scale to hundreds of autonomous trucks across the Southern US by 2026. The company also highlighted partnerships with Roush Industries and Detmar Logistics and its push into adjacent opportunities such as ride-hailing and deliveries, signaling an effort to extend its autonomous driving...

Investors may be wondering if Citizens Financial Group at US$59.97 is offering good value right now, or if the recent excitement has already been priced in. The stock has returned 1.7% over the last 7 days, 1.0% year to date, and 53.1% over the past year, while the 30 day return reflects a 0.4% decline. Recent coverage has focused on Citizens Financial Group as part of the wider US banking sector, with investors watching how large regional banks respond to the interest rate backdrop and...

In recent weeks, law firm Bronstein, Gewirtz & Grossman, LLC announced an investigation into Medical Properties Trust after the REIT disclosed a default by its third-largest tenant, Healthcare Systems of America, which represents about 8% of its total assets and is currently involved in competing lawsuits. This combination of a major tenant default and legal scrutiny raises fresh questions about Medical Properties Trust’s tenant quality, asset risk, and overall resilience. We’ll now examine...

Why Booz Allen’s latest federal win and cyber product push matter for shareholders Booz Allen Hamilton Holding (BAH) has attracted fresh attention after being chosen by the National Weather Service to build a first of its kind cloud data platform for U.S. weather forecasting tools. See our latest analysis for Booz Allen Hamilton Holding. Despite securing this National Weather Service contract and showcasing its Vellox cyber products, Booz Allen’s 1-year total shareholder return of 25.51% and...

Open Text stock moves as RSA Conference appearance approaches Open Text (NasdaqGS:OTEX) is drawing attention ahead of its March 23, 2026 appearance at the RSA Conference in San Francisco, where senior product leaders plan to discuss updates across the company’s security focused offerings. See our latest analysis for Open Text. At a share price of US$22.24, Open Text has seen a 1 day share price return of 2.82% and a 7 day share price return of 1.18%. However, its 30 day and year to date share...

Domino's Pizza (NasdaqGS:DPZ) has appointed Nicola Frampton as permanent CEO after a period as interim leader. The company has launched Chick 'N' Dip as a nationwide chicken focused sub-brand alongside its core pizza offering. These changes follow a leadership shakeup and reflect an effort to sharpen focus on pizza while building a stronger position in chicken. Domino's Pizza, through its global franchise network, is best known for delivery focused pizza and a heavily digital ordering...

The Middleby Corporation has appointed long-time finance executive Brittany Cerwin as Chief Financial Officer, effective March 25, 2026, with former CFO Bryan Mittelman becoming Special Advisor to the CEO. This leadership change comes as Mittelman concentrates on completing Middleby’s portfolio transformation, including the planned spin-off of its Food Processing business by the end of the second quarter of 2026. Now we’ll examine how Cerwin’s elevation to CFO and Mittelman’s focus on the...